STAT

OCTOBER 30, 2023

Today, we discuss why Sanofi’s stock crashed, what Sarepta’s new Duchenne data will mean for the company and the space, and say goodbye to Bristol Myers Squibb’s chief executive. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox.

Drug Development 243

Drug Development 243

STAT

OCTOBER 23, 2023

… AstraZeneca chief executive officer Pascal Soriot maintained that reports of his imminent departure are “fake news” and he feels fit enough to spend another five years at the drugmaker , Bloomberg News reports. We appreciate hearing from you. This is totally made up.

241

241

STAT

DECEMBER 11, 2023

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello from ASH! Writing this Readout from a press room at the annual hematology confab here in San Diego. Today’s edition is chockfull of Vertex content, plus some extras from ASH and elsewhere.

Drug Pricing 226

Drug Pricing Drug Development 226

STAT

JULY 6, 2023

News & World Report rankings. ” So, Penn Medicine and other nonprofits joined forces to revive the hospital, operating it at a financial loss to ensure this underserved community had access. “During the meeting with my team, someone asked, ‘Will this have an impact on our rankings?’”

Hospitals 236

Hospitals 236

STAT

NOVEMBER 28, 2023

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox.

Drug Pricing 228

Drug Pricing Drug Development 228

STAT

JANUARY 11, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.    Sign up to get it delivered in your inbox every Tuesday and Thursday.

249

249

STAT

JANUARY 3, 2024

Hello, everyone, and how are you today? We are doing fine, thank you, especially given that this is the middle of the week. Perhaps you can relate. Of course, we will forge ahead, as always, since the alternatives appear bleak. This calls for a cup of stimulation and we invite you to join us. Our choice today is cinnamon sticky bun.

264

264

STAT

OCTOBER 4, 2023

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with the precarious case of gene therapy in Europe, a long-awaited coup for Novavax, and the unwinding of Amgen’s success story. Read the rest…

Drug Development 246

Drug Development Vaccines 246

STAT

JANUARY 17, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the latest biotech startup to downsize, a novel idea in cancer treatment, and a few major catalysts on the calendar. Read the rest…

Drug Pricing 238

Drug Pricing Drug Development 238

STAT

DECEMBER 5, 2023

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Buongiorno, Nalis here! A question for you to consider: Is it fair to let the Sacklers off the hook from facing future justice, if that is the best guarantee of compensation to victims of the opioid epidemic?

Vaccines 239

Vaccines 239

STAT

NOVEMBER 30, 2023

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.    Sign up to get it delivered in your inbox every Tuesday and Thursday.     Read the rest…

Hospitals 267

Hospitals 267

pharmaphorum

OCTOBER 26, 2023

First data with subcutaneous Leqembi, and other CTAD news Phil.Taylor Thu, 26/10/2023 - 09:24 Bookmark this

104

104

Pharma Times

JUNE 20, 2023

Immunological disorder therapy data to be shared at International Conference on Redox Medicine - News - PharmaTimes

106

106

STAT

JANUARY 5, 2024

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascots, catch up on our reading, and take a nap or two.

Diabetes 236

Diabetes Medical Records Pharmaceutical Companies Pharmaceutical Companies 236

STAT

DECEMBER 4, 2023

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.

Hospitals 272

Hospitals 272

Drug Patent Watch

MAY 2, 2022

DrugPatentWatch has been named to Genetic Engineering News‘ Best of the Web list. The review by Genetic Engineering News profile highlighted the “new training modules designed to help you find….

113

113

Drug Channels

JANUARY 4, 2024

Paula and I have some exciting news to share with you: Drug Channels Institute is joining the HMP Global family! HMP is a leading omnichannel healthcare education, events, and market insights company. It’s a great fit for DCI.

73

73

STAT

JANUARY 10, 2023

Its new machines were must-haves for genetic researchers, who bought the new devices as quickly as Apple enthusiasts snapping up new iPhones. Illumina, the largest maker of DNA sequencing technology, told investors exactly what they didn’t want to hear on Monday.

249

249

STAT

MARCH 19, 2024

The news is everywhere in my social news feeds this morning: A popular fad diet is apparently lethal, scientific research says. Specifically, a study found that caloric restriction, also known as intermittent fasting, has a 91% risk of death due to cardiovascular disease.

364

364

STAT

DECEMBER 2, 2022

In 2004, Mike Rossner and Kenneth Yamada, two top editors at the Journal of Cell Biology, wrote an editorial alerting readers to what they saw as an emerging problem in science: Thanks to Photoshop, researchers could prettify the images in their manuscripts in ways that might cross the line into deception in an effort to clear the bar of peer review. (..)

270

270

Fuld & Company Blog

JANUARY 12, 2023

For the latest and most important sustainability news and developments from November and December 2022 please see below for all the key stories. For a PDF version of this news please download here. Key Sustainability News A summary of the key sustainability news that has occurred over the past month is listed below.

Hospitals 52

Hospitals Packaging 52

Pharmacy Times

OCTOBER 1, 2022

This month's generic product news features clorazepate dipotassium tablets, exemestane tablets, and paliperidone extended-release tablets.

59

59

STAT

MAY 7, 2024

Good morning, incredibly exciting news from the STAT newsroom — two of our reporters, Casey Ross and Bob Herman (or as we call them,  Bob Ross ), were  named Pulitzer finalists  in investigative reporting! Want to stay on top of the science and politics driving biotech today? 

Drug Pricing 239

Drug Pricing Drug Development 239

pharmaphorum

AUGUST 21, 2020

New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandemic continues. Here we highlight the biggest R&D, market access and digital coronavirus news of the past week.

Vaccines 104

Vaccines 104

STAT

NOVEMBER 16, 2022

Amid a bumpy few years for development in Boston, the business of building lab space has been a gleaming bright spot, with billions upon billions of dollars pouring in to house the region’s booming life science industry. Now, though, even the lab boom is slowing amid a rocky economy, rising interest rates, and soaring construction costs.

250

250

Drug Channels

APRIL 29, 2024

April is over, so it's time to hop into this month’s selection of noteworthy news: CVS Health’s formulary boosts a Humira biosimilar An insurer ditches buy-and-bill to save money for plans—but maybe not for patients?

Specialty Pharmacies 79

Specialty Pharmacies Biosimilars 79

pharmaphorum

NOVEMBER 21, 2022

At this year’s conference in Las Vegas, several pharma companies announced news at the show. Here’s a roundup of major pharma news out of HLTH. Roche announced at the show that it will be rebranding its various digital health efforts under the new brand navify – a portmanteau of navigate and clarify.

Department of Veterans Affairs 52

Department of Veterans Affairs Medical Records Communication Hospitals 52

Fuld & Company Blog

JANUARY 12, 2023

For the latest and most important 5G news and developments from November and December 2022 please see below for all the key stories. For a PDF version of this news please download here. The post 5G News and Trends – January 2023 appeared first on Fuld & Co.

Communication 52

Communication 52

Fuld & Company Blog

JANUARY 12, 2023

Every month we publish the latest news and developments relating to Corporate Venture Capital (CVC). If you would like a PDF version of this news please download here. Key Corporate Venture Capital News A summary of the key Corporate Venture Capital news that has occurred over the past month is listed below.

52

52

Outsourcing Pharma

APRIL 12, 2024

Yesterday's migraine treatment breakthrough, though amidst a complex journey to find a cure, still promises a dramatic impact despite the absence of a 'magic bullet.'

98

98

Drug Channels

FEBRUARY 27, 2024

February is longer than usual this year, which means that you’ll have extra time to leap into our monthly curated selection of noteworthy news.

Drug Pricing 68

Drug Pricing 68

Outsourcing Pharma

MARCH 21, 2024

AstraZeneca recently announced its Â650 million investment in the UK, held up by Chancellor Jeremy Hunt as a âvote of confidenceâ in the countryâs life sciences sector.

97

97

pharmaphorum

AUGUST 14, 2020

Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories. A new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset and therapy app that claims to have similar beneficial effects to drugs but with fewer side-effects.

Vaccines 98

Vaccines Hospitals 98

STAT

APRIL 24, 2024

 The news follows the discovery that the avian flu has been detected in dairy cows. Genetic evidence of the H5N1 bird flu virus was  found in grocery store milk in the United States this week, according to the Food and Drug Administration. The But what do traces of virus in pasteurized milk mean for consumers?

Grocery Stores 296

Grocery Stores 296

pharmaphorum

FEBRUARY 3, 2022

” The post No news anytime soon on Sandoz sale, says Novartis appeared first on. Novartis also revealed during the update that it had discontinued development of CEE321, a pan-JAK inhibitor that had been in early clinical testing for atopic dermatitis, because of an “unfavourable benefit/risk profile.”

Biosimilars 98

Biosimilars 98

STAT

SEPTEMBER 27, 2023

It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?” Yet when T.J.

360

360

pharmaphorum

JANUARY 29, 2021

The post Bad news for Pfizer as blockbuster Xeljanz flunks safety study appeared first on. Some analysts think the fallout from the ORAL Surveillance could extend to other drugs in the JAK class, and encourage greater use of TNF blockers whilst leaving a big potential market open for other anti-inflammatories coming through development.

Labelling 135

Labelling 135